Home ›
Data Desk › Late 10-Q notice from RetinalGenix Technologies Inc.
MarginsX Data Desk · Late filings · FDA approval · Going-concern doubt · Material weakness
Late 10-Q notice from RetinalGenix Technologies Inc. With an NT 10-Q filed Nov 13, 2026, RetinalGenix Technologies Inc. (RTGN) told the SEC its 10-Q will miss the deadline. (SEC EDGAR, NT 10-Q, Nov 13, 2026)
By the MarginsX Data Desk, automated. Published November 14, 2026. Data as of November 13, 2026.
The stock
Its market value is about $75.2M, from the latest close and its SEC share count. (Latest close times the SEC cover-page share count, Nov 12, 2026 )
Follow it up
The company's page on MarginsX, with its filings, health check and ownership. (capital.sophiaxt.com/stocks/RTGN )
The filing on SEC EDGAR. (sec.gov )
Automated from SEC filings and market data by the MarginsX Data Desk, written by template with no AI. For information only. Not investment advice.
Facts behind this article Fact Value Source As of Late form 10-Q Source 2026-11-13 Name RetinalGenix Technologies Inc. Source 2026-11-12 Form NT 10-Q Source 2026-11-13 Filed Nov 13, 2026 Source 2026-11-13 Who RetinalGenix Technologies Inc. (RTGN) Source 2026-11-12 Symbol RTGN Source 2026-11-12 Cap 75,186,075.9 USD Source 2026-11-12
Sources
Automated from SEC filings and market data. No AI. For information only. Not investment advice.
Discuss in MarginsX More from the Data Desk
More on MarginsX Companies in this article Topics Related Data Desk stories Every Data Desk article: /desk · RSS